BRIEF-Intelgenx Technologies announces notice of appeal for Buprenorphine/Naloxone
July 11 (Reuters) - Intelgenx Technologies Corp :
* Intelgenx announces notice of appeal for buprenorphine/naloxone sublingual film product for the treatment of opiate addiction
* Court ruled par's anda product would infringe asserted claims of u.s. Patent no. 8,603,514
* Court rule one of orange book listed patents for suboxone film, claims of u.s. Patent no. 8,603,514 were not shown to be invalid Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.